Kintor Pharmaceutical Limited

OTCPK:KNTP.F Stock Report

Market Cap: US$52.3m

Kintor Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:KNTP.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Dec 24BuyUS$33,365Youzhi TongIndividual238,000US$0.14
30 Oct 24BuyUS$5,661Youzhi TongIndividual40,000US$0.14
29 Oct 24BuyUS$3,086Youzhi TongIndividual22,000US$0.14
25 Oct 24BuyUS$13,770Youzhi TongIndividual100,000US$0.14
15 Oct 24BuyUS$43,691Youzhi TongIndividual288,000US$0.15
14 Oct 24BuyUS$17,587Youzhi TongIndividual112,000US$0.16
09 Oct 24BuyUS$31,906Youzhi TongIndividual200,000US$0.16
02 Oct 24BuyUS$25,471Youzhi TongIndividual154,500US$0.16
27 Sep 24BuyUS$47,948Youzhi TongIndividual345,500US$0.14
26 Sep 24BuyUS$44,410Youzhi TongIndividual350,000US$0.13
25 Sep 24BuyUS$12,203Youzhi TongIndividual100,000US$0.12
24 Sep 24BuyUS$6,165Youzhi TongIndividual50,000US$0.12
23 Sep 24BuyUS$12,010Youzhi TongIndividual100,000US$0.12
20 Sep 24BuyUS$48,942Youzhi TongIndividual400,000US$0.12
19 Sep 24BuyUS$23,388Youzhi TongIndividual194,000US$0.12
17 Sep 24BuyUS$14,918Youzhi TongIndividual125,000US$0.12
13 Sep 24BuyUS$31,926Youzhi TongIndividual281,000US$0.11
12 Sep 24BuyUS$20,262Youzhi TongIndividual186,000US$0.11
09 Sep 24BuyUS$21,371Youzhi TongIndividual190,000US$0.11
05 Sep 24BuyUS$53,685Youzhi TongIndividual464,500US$0.12
04 Sep 24BuyUS$12,524Youzhi TongIndividual105,000US$0.12
03 Sep 24BuyUS$54,898Youzhi TongIndividual454,500US$0.12
25 Jul 24BuyUS$37,722Youzhi TongIndividual295,500US$0.13
25 Jul 24BuyUS$25,490Youzhi TongIndividual200,000US$0.13
24 Jul 24BuyUS$12,230Youzhi TongIndividual95,500US$0.13

Insider Trading Volume

Insider Buying: KNTP.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KNTP.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions19,055,9604.4%
VC/PE Firms24,873,5005.74%
Individual Insiders46,500,27010.7%
General Public342,535,51879.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 6 shareholders own 20.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Youzhi Tong
46,500,270US$5.6m2.55%no data
5.74%
Zhuhai Gree Financial Investment Management Co., Ltd.
24,873,500US$3.0m0%0.61%
4.2%
Nomura Holdings Inc, Securities & Investment Arm
18,183,792US$2.2m0%0.01%
0.19%
GF Fund Management Co., Ltd.
841,000US$101.6k0%no data
0.0066%
Dimensional Fund Advisors LP
28,500US$3.4k0%no data
0.00062%
BMO Asset Management Corp.
2,668US$324.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 04:17
End of Day Share Price 2024/11/01 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kintor Pharmaceutical Limited is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peng ZouChina International Capital Corporation Limited
Bing ZhaoChina Renaissance Securities
Blanco ZhouChina Renaissance Securities